Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F

Journal of Immunology

Volumn 179, Issue 8, 2007, Pages 5462-5473

  Kuestner, Rolf E ^a   Taft, David W ^a   Haran, Aaron ^a   Brandt, Cameron S ^a   Brender, Ty ^a   Lum, Karen ^a   Harder, Brandon ^a   Okada, Shannon ^a   Ostrander, Craig D ^a   Kreindler, James L ^b   Aujla, Shean J ^b   Reardon, Brian ^a   Moore, Margaret ^a   Shea, Pamela ^a   Schreckhise, Randall ^a   Bukowski, Thomas R ^a   Presnell, Scott ^a   Guerra Lewis, Patricia ^a   Parrish Novak, Julia ^a   Ellsworth, Jeff L ^a   Jaspers, Stephen ^a   Lewis, Katherine E ^a   Appleby, Mark ^a   Kolls, Jay K ^b   Rixon, Mark ^a   West, James W ^a   Gao, Zeren ^a   Levin, Steven D ^a   more..

^a ZYMOGENETICS INC   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 17 RECEPTOR C; INTERLEUKIN 17F; MESSENGER RNA; UNCLASSIFIED DRUG; AUTACOID;

ADRENAL GLAND; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BINDING AFFINITY; BINDING KINETICS; CONTROLLED STUDY; DISEASE MODEL; EPITHELIUM CELL; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC CONSERVATION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG LAVAGE; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RESPIRATORY EPITHELIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SPECIES DIFFERENCE; ALTERNATIVE RNA SPLICING; ANIMAL; BAGG ALBINO MOUSE; BINDING COMPETITION; CELL LINE; DRUG ANTAGONISM; GENETIC TRANSFECTION; GENETICS; HAMSTER; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PROTEIN BINDING;

ALTERNATIVE SPLICING; ANIMALS; BINDING, COMPETITIVE; CELL LINE; CRICETINAE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-17; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RECEPTORS, INTERLEUKIN-17; SPECIES SPECIFICITY; TRANSFECTION;

EID: 38449094307     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.8.5462     Document Type: Article

References (36)

1. Spriggs, M. K. 1997. Interleukin-17 and its receptor. J. Clin. Immunol. 17: 366-369.
2. Yao, Z., W. C. Fanslow, M. F. Seldin, A. M. Rousseau, S. L. Painter, M. R. Comeau, J. I. Cohen, and M. K. Spriggs. 1995. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3: 811-821.
3. Moseley, T. A., D. R. Haudenschild, L. Rose, and A. H. Reddi. 2003. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14: 155-174.
4. Kolls, J. K., and A. Linden. 2004. Interleukin-17 family members and inflammation. Immunity 21: 467-476.
5. Kawaguchi, M., M. Adachi, N. Oda, F. Kokubu, and S. K. Huang. 2004. IL-17 cytokine family. J. Allergy Clin. Immunol. 114: 1265-1273.
6. Aggarwal, S., N. Ghilardi, M. H. Xie, F. J. de Sauvage, and A. L. Gurney. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278: 1910-1914.
7. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240.
8. McKenzie, B. S., R. A. Kastelein, and D. J. Cua. 2005. Understanding the IL-23 IL-17 immune pathway. Trends Immunol. 27: 17-23.
9. Starnes, T., M. J. Robertson, G. Sledge, S. Kelich, H. Nakshatri, H. E. Broxmeyer, and R. Hromas. 2001. Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J. Immunol. 167: 4137-4140.
10. Yao, Z., S. L. Painter, W. C. Fanslow, D. Ulrich, B. M. Macduff, M. K. Spriggs, and R. J. Armitage. 1995. Human IL-17: a novel cytokine derived from T cells. J. Immunol. 155: 5483-5486.
11. McAllister, F., A. Henry, J. L. Kreindler, P. J. Dubin, L. Ulrich, C. Steele, J. D. Finder, J. M. Pilewski, B. M. Carreno, S. J. Goldman, et al. 2005. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-α and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J. Immunol. 175: 404-412.
12. Lubberts, E. 2003. The role of IL-17 and family members in the pathogenesis of arthritis. Curr. Opin. Investig. Drugs 4: 572-577.
13. Oda, N., P. B. Canelos, D. M. Essayan, B. A. Plunkett, A. C. Myers, and S. K. Huang. 2005. Interleukin-17F induces pulmonary neutrophilia and amplifies Ag-induced allergic response. Am. J. Respir. Crit. Care Med. 171: 12-18.
14. Gaffen, S. L. 2004. Biology of recently discovered cytokines: interleukin-17, a unique inflammatory cytokine with roles in bone biology and arthritis. Arthritis Res. Ther. 6: 240-247.
15. Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141.
16. Lock, C., G. Hermans, R. Pedotti, A. Brendolan, E. Schadt, H. Garren, A. Langer-Gould, S. Strober, B. Cannella, J. Allard, et al. 2002. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8: 500-508.
17. Murphy, C. A., C. L. Langrish, Y. Chen, W. Blumenschein, T. McClanahan, R. A. Kastelein, J. D. Sedgwick, and D. J. Cua. 2003. Divergent pro and anti-inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198: 1951-1957.
18. Honorati, M. C., S. Neri, L. Cattini, and A. Facchini. 2005. Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts. Osteoarthritis Cartilage 14: 345-352.
19. Granet, C., and P. Miossec. 2004. Combination of the proinflammatory cytokines IL-1, TNF-α, and IL-17 leads to enhanced expression and additional recruitment of AP-1 family members, Egr-1 and NF-κB in osteoblast-like cells. Cytokine 26: 169-177.
20. Miossec, P. 2004. IL-17 in rheumatoid arthritis: a new target for treatment or just another cytokine? Joint Bone Spine 71: 87-90.
21. Chabaud, M., G. Page, and P. Miossec. 2001. Enhancing effect of IL-1, IL-17, and TNF-α on macrophage inflammatory protein-3α production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines. J. Immunol. 167: 6015-6020.
22. Fujino, S., A. Andoh, S. Bamba, A. Ogawa, K. Hata, Y. Araki, T. Bamba, and Y. Fujiyama. 2003. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52: 65-70.
23. Nielsen, O. H., I. Kirman, N. Rudiger, J. Hendel, and B. Vainer. 2003. Up-regulation of interleukin-12 and -17 in active inflammatory bowel disease. Scand. J. Gastroenterol. 38: 180-185.
24. Mangan, P. R., L. E. Harrington, D. B. O'Quinn, W. S. Helms, D. C. Bullard, C. O. Elson, R. D. Hatton, S. M. Wahl, T. R. Schoeb, and C. T. Weaver. 2006. Transforming growth factor-β induces development of the TH17 lineage. Nature 441: 231-234.
25. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
26. Weaver, C. T., L. E. Harrington, P. R. Mangan, M. Gavrieli, and K. M. Murphy. 2006. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24: 677-688.
27. Lee, J., W. H. Ho, M. Maruoka, R. T. Corpuz, D. T. Baldwin, J. S. Foster, A. D. Goddard, D. G. Yansura, R. L. Vandlen, W. I. Wood, and A. L. Gurney. 2001. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J. Biol. Chem. 276: 1660-1664.
28. Toy, D., D. Kugler, M. Wolfson, T. Vanden Bos, J. Gurgel, J. Derry, J. Tocker, and J. Peschon. 2006. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J. Immunol. 177: 36-39.
29. Haudenschild, D., T. Moseley, L. Rose, and A. H. Reddi. 2002. Soluble and transmembrane isoforms of novel interleukin-17 receptor-like protein by RNA splicing and expression in prostate cancer. J. Biol. Chem. 277: 4309-4316.
30. Gray, T. E., K. Guzman, C. W. Davis, L. H. Abdullah, and P. Nettesheim. 1996. Mucociliary differentiation of serially passaged normal human tracheobronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 14: 104-112.
31. Hymowitz, S. G., E. H. Filvaroff, J. P. Yin, J. Lee, L. Cai, P. Risser, M. Maruoka, W. Mao, J. Foster, R. F. Kelley, et al. 2001. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J. 20: 5332-5341.
32. Chang, S. H., H. Park, and C. Dong. 2006. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J. Biol. Chem. 281: 35603-35607.
33. Qian, Y., C. Liu, J. Hartupee, C. Z. Altuntas, M. F. Gulen, D. Jane-Wit, J. Xiao, Y. Lu, N. Giltiay, J. Liu, et al. 2007. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat. Immunol. 8: 232-234.
34. Schwandner, R., K. Yamaguchi, and Z. Cao. 2000. Requirement of TNF receptor-associated factor (TRAF) 6 in interleukin 17 signal transduction. J. Exp. Med. 191: 1233-1240.
35. Awane, M., P. G. Andres, D. J. Li, and H. C. Reinecker. 1999. NF-κB-inducing kinase is a common mediator of IL-17-, TNF-α-, and IL-1 β-induced chemokine promoter activation in intestinal epithelial cells. J. Immunol. 162: 5337-5344.
36. + T cells. J. Biol. Chem. 282: 13447-13455.